DANA BURNS: Open Payments
NPI 1538825344 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 1 | $130 |
| ABBVIE INC. | 1 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Integra LifeSciences Corporation | 1 | $42 |
| GENZYME CORPORATION | 2 | $31 |
| Kerecis Limited | 1 | $23 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, NUCALA, ACCLARENT AERA, Kerecis SurgiClose.
Industry payments across TX — which companies pay providers there.
